V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003196 | 210012294 | 1.52 | 56.9 | Adjuvant (A) | 2017-02-22 | 2017-06-01 | Docetaxel | 02 | N | DOCETAXEL | 100632279 |
| 210003199 | 210012295 | 1.72 | 103.4 | null | 2017-10-10 | 2017-11-02 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100272287 |
| 210003203 | 210012296 | 1.68 | 72.5 | Palliative (P) | 2021-07-07 | 2021-07-29 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101584040 |
| 210003204 | 210012297 | null | 57.7 | Adjuvant (A) | null | 2017-08-02 | Docetaxel | 02 | N | DOCETAXEL | 100067574 |
| 210003207 | 210012298 | 1.7 | 81 | null | 2018-08-01 | 2018-08-06 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101081006 |
| 210003216 | 210012300 | 1.62 | 54.8 | Adjuvant (A) | 2020-01-02 | 2020-01-16 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100277260 |
| 210003218 | 210012302 | 1.56 | 57.5 | Neo-adjuvant (N) | 2019-06-01 | 2019-06-16 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101162900 |
| 210003220 | 210012303 | null | 63.6 | null | 2017-11-13 | 2018-03-28 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100029122 |
| 210003221 | 210012304 | 1.56 | null | Adjuvant (A) | 2020-09-27 | 2020-10-14 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100633312 |
| 210003222 | 210012305 | 1.47 | 56.7 | null | null | 2021-10-28 | Docetaxel | 02 | null | DOCETAXEL | 100507774 |
| 210003223 | 210012306 | 1.67 | 80.9 | Adjuvant (A) | 2017-04-01 | 2017-06-24 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 101712169 |
| 210003225 | 210012307 | 1.61 | 77 | Palliative (P) | 2018-06-18 | 2018-06-19 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101114576 |
| 210003232 | 210012309 | 1.56 | 60.6 | null | null | 2020-08-15 | PACLITAXEL | 02 | null | PACLITAXEL | 100731432 |
| 210003240 | 210012310 | 1.61 | 105.7 | Adjuvant (A) | null | 2021-05-21 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101309644 |
| 210003245 | 210012312 | 1.7 | 76.2 | Adjuvant (A) | 2017-04-05 | 2017-06-17 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101272057 |
| 210003257 | 210012313 | 1.49 | 69.1 | Palliative (P) | 2020-04-11 | 2020-11-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 101116878 |
| 210003260 | 210012314 | 1.61 | 68.3 | null | 2017-04-09 | 2017-04-16 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101642636 |
| 210003263 | 210012316 | 1.51 | 83.5 | Adjuvant (A) | 2019-01-11 | 2019-01-12 | Trastuzumab | null | N | TRASTUZUMAB | 101824256 |
| 210003271 | 210012318 | 1.68 | 115 | null | 2019-04-22 | 2019-05-27 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100350490 |
| 210003275 | 210012319 | null | 61.8 | Neo-adjuvant (N) | null | 2021-02-20 | Docetaxel | 02 | N | DOCETAXEL | 101657148 |
| 210003277 | 210012320 | 1.69 | 77.6 | Neo-adjuvant (N) | 2020-01-03 | 2020-01-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100163578 |
| 210003278 | 210012321 | 1.65 | 54.8 | null | null | 2019-01-15 | Paclitaxel 7 day | null | N | PACLITAXEL | 100603073 |
| 210003282 | 210012322 | null | 55.3 | Neo-adjuvant (N) | 2018-04-17 | 2018-07-17 | PACLITAXEL | 02 | N | PACLITAXEL | 100093197 |
| 210003284 | 210012324 | 1.57 | 88.4 | Adjuvant (A) | null | 2016-07-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101831786 |
| 210003287 | 210012325 | 1.52 | 54.7 | Palliative (P) | 2018-10-25 | 2019-02-15 | Docetaxel | 02 | N | DOCETAXEL | 100051775 |
| 210003295 | 210012326 | null | 0 | Neo-adjuvant (N) | 2020-05-14 | 2020-05-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101706298 |
| 210003296 | 210012327 | null | null | Adjuvant (A) | null | 2020-07-04 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100768044 |
| 210003297 | 210012328 | 1.61 | 70.8 | Curative (C) | 2020-09-03 | 2020-09-16 | Trastuzumab | 02 | N | TRASTUZUMAB | 101440982 |
| 210003299 | 210012329 | 1.66 | 75.8 | Adjuvant (A) | 2019-10-29 | 2019-10-29 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101705452 |
| 210003300 | 210012330 | 1.63 | 89.8 | Neo-adjuvant (N) | 2019-12-09 | 2020-02-20 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100201936 |
| 210003302 | 210012331 | 1.65 | null | null | 2018-10-04 | 2020-01-26 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100588109 |
| 210003304 | 210012332 | 0 | 87 | Neo-adjuvant (N) | 2021-01-13 | 2021-04-21 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100561238 |
| 210003309 | 210012333 | 1.73 | null | Adjuvant (A) | 2019-05-26 | 2019-06-08 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100412354 |
| 210003312 | 210012334 | 1.61 | 104.4 | Adjuvant (A) | 2018-09-12 | 2018-10-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100032054 |
| 210003313 | 210012335 | 1.52 | 73 | Palliative (P) | 2018-09-23 | 2018-09-23 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101271455 |
| 210003315 | 210012337 | 1.64 | 64 | Adjuvant (A) | null | 2022-03-30 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101120071 |
| 210003325 | 210012339 | 1.51 | 0 | null | 2021-01-15 | 2021-01-23 | PACLITAXEL | 02 | N | PACLITAXEL | 100793026 |
| 210003326 | 210012340 | 1.65 | 67.25 | Neo-adjuvant (N) | null | 2019-10-24 | Docetaxel | 02 | N | DOCETAXEL | 101671812 |
| 210003328 | 210012341 | 1.55 | 151 | Adjuvant (A) | 2019-09-19 | 2019-11-28 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101346546 |
| 210003332 | 210012343 | 1.54 | 65.5 | Not known (9) | 2019-08-13 | 2019-09-16 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101530185 |
| 210003333 | 210012344 | 1.61 | 71.1 | Adjuvant (A) | 2020-01-13 | 2020-02-17 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100273998 |
| 210003334 | 210012345 | 0 | 83.4 | Adjuvant (A) | 2017-07-12 | 2019-01-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100478602 |
| 210003336 | 210012346 | 1.67 | 92 | Palliative (P) | 2017-06-02 | 2017-07-08 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100446841 |
| 210003339 | 210012347 | 1.65 | 90.7 | null | null | 2017-05-31 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101171326 |
| 210003341 | 210012348 | 1.63 | 80.6 | Adjuvant (A) | 2019-06-08 | 2019-06-23 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101829987 |
| 210003342 | 210012349 | 1.58 | null | null | 2021-05-17 | 2021-12-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100510666 |
| 210003344 | 210012350 | 1.6 | 58 | Adjuvant (A) | null | 2018-02-22 | PACLITAXEL | 02 | N | PACLITAXEL | 100143902 |
| 210003348 | 210012351 | 1.53 | 89 | Adjuvant (A) | 2020-10-14 | 2021-03-25 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100405639 |
| 210003351 | 210012352 | 1.51 | 69.7 | Neo-adjuvant (N) | 2022-01-03 | 2022-04-01 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101572905 |
| 210003352 | 210012353 | 1.68 | 102 | null | null | 2017-05-01 | Docetaxel | null | null | DOCETAXEL | 100260471 |